340B PARTNERSHIPS BETWEEN STATES AND COVERED ENTITIES

1 / 13
About This Presentation
Title:

340B PARTNERSHIPS BETWEEN STATES AND COVERED ENTITIES

Description:

Federal Discounts. NCSL Web-Assisted Audioconference. Health Care Series. October 15, 2003 ... 340B Opportunities For States: Extension To Prisons ... – PowerPoint PPT presentation

Number of Views:1084
Avg rating:3.0/5.0
Slides: 14
Provided by: denise3
Learn more at: http://ecom.ncsl.org

less

Transcript and Presenter's Notes

Title: 340B PARTNERSHIPS BETWEEN STATES AND COVERED ENTITIES


1
340B PARTNERSHIPS BETWEEN STATES AND COVERED
ENTITIES
  • by
  • Bill von Oehsen
  • Principal
  • Powers Pyles Sutter Verville, PC
  • Prescription Drugs How States Can Use
  • Federal Discounts
  • NCSL Web-Assisted Audioconference
  • Health Care Series
  • October 15, 2003

2
Background On U.S. Pharmaceutical Market
Comparison Of Prices
Private Sector Pricing
Best Price
Source Stephen Schondelmeyer, PRIME Institute,
University of Minnesota. Data derived from
Prescription Drugs Expanding Access to Federal
Prices Could Cause Other Price Changes, U.S.
General Accounting Office, GAO/HEHS-00-118,
August 2000 and How the Medicaid Rebate on
Prescription Drugs Affects Pricing in the
Pharmaceutical Market, Congressional Budget
Office Papers, January 1996.
Powers Pyles Sutter Verville, PC
Bill von Oehsen
(202) 466-6550
William.vonOehsen_at_ppsv.com
3
Background On U.S. Drug Market Comparison Of
Prices
100.0
Average Wholesale Price
80.0
60.5
49.0
Cash Customers
44.8
PBM and Other Private Insurance
Medicaid
FSS
340B
Market Share
VA
25
60
11
1
1
1
Market Share
Chart is based on rough estimates
Powers Pyles Sutter Verville, PC
Bill von Oehsen (202)
466-6550
William.vonOehsen_at_ppsv.com
4
Medicare Drug BenefitPossible Impact Of Lower
Prices
100.0
Average Wholesale Price
Price Reduction for Medicare Patients
80.0
60.5
51.7
49.0
44.8
Cash Customers
Medicaid
PBM and Other Private Insurance
FSS
340B
Market Share
VA
25
60
11
Market Share
1
1
1
Chart is based on rough estimates
5
Medicare Drug BenefitPossible Impact Of Lower
Prices
Average Wholesale Price
51.7
49.0
Cash Customers
44.8
PBM and Other Private Insurance
100.0
Medicare
80.0
Medicaid
60.5
Market Share
340B
VA
40
11
10
35
Market Share
1
1
1
Chart is based on rough estimates
Powers Pyles Sutter Verville, PC
Bill von Oehsen (202) 466-6550
William.vonOehsen_at_ppsv.com
6
340B Opportunities For States
  • Encouraging eligible facilities within the state
    to enroll in 340B
  • Using 340B-discounted drugs for state and county
    prisoners
  • Maximizing use of 340B within state-funded
    managed care plans
  • Including 340B providers in state bulk purchasing
    initiatives
  • Sole source contracts with 340B providers to
    furnish high-cost chronic care drugs

Powers Pyles Sutter Verville, PC
Bill von Oehsen (202)
466-6550
William.vonOehsen_at_ppsv.com
7
340B Opportunities For States Encouraging 340B
Participation
  • 340B program reduces Medicaid reimbursement for
    outpatient drugs because 340B providers are
    required to bill Medicaid substantially below
    state reimbursement rates to offset state loss of
    rebates
  • For example, according to a recent analysis, 340B
    hospitals are saving state Medicaid programs an
    average of almost 300,000 per hospital per year
  • Many hospitals, community health centers, and
    other eligible facilities are not participating
    in 340B
  • By assisting eligible entities with 340B
    enrollment, states can lower their Medicaid drug
    expenditures

Powers Pyles Sutter Verville, PC
Bill von
Oehsen (202) 466-6550
William.vonOehsen_at_ppsv
.com
8
340B Opportunities For States Extension To
Prisons
  • States and counties may contract with 340B
    hospitals or other 340B facilities to provide
    health care services, including pharmacy
    services, to correctional populations
  • Prisoners must be patients of the 340B provider
    to be eligible to receive discounted drugs
  • Texas implemented this approach as a result of
    legislation passed in 2001 (S.B. 347)
  • This partnership strategy is being pursued by
    state and local governments to extend 340B
    pricing to mental health populations, and recent
    Texas legislation (H.B. 2292) specifically
    encourages this concept

Powers Pyles Sutter Verville, PC Bill von
Oehsen (202) 466-6550
William.vonOehsen_at_ppsv.com
9
340B Opportunities For States State-Funded
Managed Care
  • Drugs are about 35 percent more costly when
    purchased through PBMs instead of 340B program
  • Shifting drug purchases from PBMs to 340B
    providers can lower costs for the plan which can
    be passed on
  • to the state
  • For Medicaid programs, this is an alternative to
    states carving out pharmacy from the plans
    benefits package and returning it to a
    fee-for-service program in order to collect
    Medicaid rebates.
  • Application to managed care plans for state
    employees?

Powers Pyles Sutter Verville, PC Bill von
Oehsen (202) 466-6550
William.vonOehsen_at_ppsv.com
10
Managed Care Disease Management
  • 340B providers participating in managed care
    plans can develop disease management programs for
    enrollees having high drug costs
  • Plans can steer enrollees suffering from chronic
    diseases to these 340B-based disease management
    programs (e.g., AIDS, diabetes, asthma, heart
    disease, etc.)
  • 340B providers can use mail order or contracted
    retail pharmacies to increase access by getting
    federal approval as an alternative methods
    demonstration project

Powers Pyles Sutter Verville, PC Bill von
Oehsen (202) 466-6550
William.vonOehsen_at_ppsv.com
11
340B Opportunities For States Bulk Purchasing
  • Volume plus preferred drug list moves market
    share and creates savings
  • By pooling their volumes, 340B providers and
    states can theoretically negotiate better
    discounts
  • Savings equals subceiling discounts for 340B
    covered entities and supplemental rebates for
    state
  • In states pursuing supplemental rebates for
    Medicaid drugs, a 340B strategy could be applied
    to disease groups carved out of the supplemental
    rebate program
  • For state purchases that do not qualify for best
    price exemption (schools, employees, etc.),
    two-tiered price negotiations will be needed

Powers Pyles Sutter Verville, PC Bill von
Oehsen (202) 466-6550
William.vonOehsen_at_ppsv.com
12
340B Opportunities for States Bulk Purchasing
State Mental Employees Prisons Schools H
ealth AMP

Rebates or Upfront Discounts
Best Price
P R I C E S
State Pharmacy Assistance Programs
Medicaid
340B
Supplemental Rebates/Subceiling Pricing
Powers Pyles Sutter Verville, PC
Bill von Oehsen (202) 466-6550
William.vonOehsen_at_ppsv.com
13
340B Opportunities For States Sole Source
Contracts
  • To meet patient definition requirements, 340B
    provider must provide other services than
    pharmacy case management and disease management
    are possibilities
  • For Medicaid, a 1915(b) or 1115 waiver is
    required to waive the patients freedom of choice
  • Utah Medicaid program has a sole source contract
    with University of Utah for providing factor
    products and case management services to
    hemophilia population statewide

Powers Pyles Sutter Verville, PC Bill von
Oehsen (202) 466-6550
William.vonOehsen_at_ppsv.com
Write a Comment
User Comments (0)